You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 11, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Christina Nedeva1, Suresh Mathivanan2
1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. C.Nedev@latrobe.edu.au.
Extracellular vesicles (EVs) are promising nanocarriers for cancer drug delivery due to their biocompatibility and targeting abilities. Engineering EVs and optimizing cargo loading are key to overcoming challenges for clinical translation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: